Results 211 to 220 of about 306,666 (265)

MiR-34a deficiency enhances nucleic acid sensing and type I IFN signaling in a mouse model of Alzheimer's disease. [PDF]

Front Immunol
Yang J, Tsourdinis GE, Holas C, Maienschein-Cline M, Lalonde R, Fukuchi KI.   +5 more
europepmc   +1 more source

Role and mechanism of gut microbiota in regulating interferon-mediated programmed cell death in colorectal cancer. [PDF]

Front Immunol
Yao Q, Chen S, Qian W, Yang C, Li J.
europepmc   +1 more source

TBKBP1 induces capecitabine resistance through negative regulation of type I interferon pathway in triple-negative breast cancer. [PDF]

Oncogene
Wu WY, Yang YS, Andriani L, Xie YF, Di GH, Shao ZM, Li JJ.   +6 more
europepmc   +1 more source

Oropouche virus infects primary human intestinal organoids and is inhibited by type I and III interferon treatment. [PDF]

mBio
Wang X, Li J, Biharie A, de Vries AC, Bijvelds MJC, Janssen HLA, Wang W, Souza WMd, Pan Q.   +8 more
europepmc   +1 more source

CFTR modulators partially restore the epithelial interferome in Aspergillus infection to improve clinical outcome. [PDF]

EBioMedicine
Laverty SL, Felton I, Casey M, Hopwood B, Simmonds N, Armstrong-James D, Shah A, Kelleher P.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Type I Interferons in Autoimmunity

Journal of Investigative Dermatology, 2022
Dysregulated IFN-1 responses play crucial roles in the development of multiple forms of autoimmunity. Many patients with lupus, systemic sclerosis, Sjogren's syndrome, and dermatomyositis demonstrate enhanced IFN-1 signaling. IFN-1 excess is associated with disease severity and autoantibodies and could potentially predict response to newer therapies ...
Ruth Fernandez-Ruiz, Timothy B. Niewold
openaire   +2 more sources